Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-110,100
Closed -$4.42M 59
2016
Q1
$4.42M Buy
110,100
+400
+0.4% +$16.1K 0.24% 42
2015
Q4
$4.68M Hold
109,700
0.26% 41
2015
Q3
$5.21M Sell
109,700
-2,700
-2% -$137K 0.29% 33
2015
Q2
$5.57M Hold
112,400
0.28% 34
2015
Q1
$5.56M Buy
112,400
+49,600
+79% +$2.37M 0.28% 32
2014
Q4
$2.86M Buy
62,800
+4,900
+8% +$238K 0.18% 46
2014
Q3
$3.27M Buy
57,900
+45,800
+379% +$2.46M 0.19% 44
2014
Q2
$643K Sell
12,100
-839,230
-99% -$44.5M 0.04% 45
2014
Q1
$44.5M Sell
851,330
-52,790
-6% -$2.67M 2.87% 19
2013
Q4
$48.5M Sell
904,120
-15,875
-2% -$819K 3.44% 12
2013
Q3
$46.6M Sell
919,995
-24,700
-3% -$1.26M 3.67% 8
2013
Q2
$48.7M Buy
+944,695
New +$50.3M 4% 4

Other funds holding SNY

M.D. Sass LLC's SNY Position: Q2 2016 in Review

M.D. Sass LLC sold out of Sanofi (SNY) in Q2 2016, closing a stake of 110,100 shares — an estimated $4.42M sold.

M.D. Sass LLC first reported a position in SNY in Q2 2013 and held it in 12 quarters. The position peaked at $48.7M in Q2 2013. 450 funds tracked by Wall St. Rank hold SNY as of Q2 2016.

  • M.D. Sass LLC reported no remaining Sanofi position as of Q2 2016 after selling out during the quarter.
  • M.D. Sass LLC sold 110,100 Sanofi shares in Q2 2016, an estimated $4.42M.
  • M.D. Sass LLC first reported a position in Sanofi in Q2 2013 and held it in 12 quarters.
  • M.D. Sass LLC's Sanofi position peaked at $48.7M in Q2 2013.
  • 450 funds tracked by Wall St. Rank held Sanofi as of Q2 2016.

Based on M.D. Sass LLC's 13F filing for Q2 2016, filed 11 Aug 2016.